JP2008517948A5 - - Google Patents

Download PDF

Info

Publication number
JP2008517948A5
JP2008517948A5 JP2007538181A JP2007538181A JP2008517948A5 JP 2008517948 A5 JP2008517948 A5 JP 2008517948A5 JP 2007538181 A JP2007538181 A JP 2007538181A JP 2007538181 A JP2007538181 A JP 2007538181A JP 2008517948 A5 JP2008517948 A5 JP 2008517948A5
Authority
JP
Japan
Prior art keywords
therapeutic composition
progenitor cells
myeloid progenitor
cells
expanded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007538181A
Other languages
English (en)
Japanese (ja)
Other versions
JP5519108B2 (ja
JP2008517948A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/038500 external-priority patent/WO2006047569A2/en
Publication of JP2008517948A publication Critical patent/JP2008517948A/ja
Publication of JP2008517948A5 publication Critical patent/JP2008517948A5/ja
Application granted granted Critical
Publication of JP5519108B2 publication Critical patent/JP5519108B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007538181A 2004-10-25 2005-10-25 骨髄細胞集団の増殖方法及びその使用 Expired - Fee Related JP5519108B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62231804P 2004-10-25 2004-10-25
US60/622,318 2004-10-25
PCT/US2005/038500 WO2006047569A2 (en) 2004-10-25 2005-10-25 Methods of expanding myeloid cell populations and uses thereof

Publications (3)

Publication Number Publication Date
JP2008517948A JP2008517948A (ja) 2008-05-29
JP2008517948A5 true JP2008517948A5 (https=) 2012-04-12
JP5519108B2 JP5519108B2 (ja) 2014-06-11

Family

ID=36228409

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007538181A Expired - Fee Related JP5519108B2 (ja) 2004-10-25 2005-10-25 骨髄細胞集団の増殖方法及びその使用

Country Status (14)

Country Link
US (7) US8252587B2 (https=)
EP (2) EP1812555B1 (https=)
JP (1) JP5519108B2 (https=)
KR (2) KR101544292B1 (https=)
CN (2) CN105168250B (https=)
AU (1) AU2005299379B2 (https=)
BR (1) BRPI0516969A (https=)
CA (1) CA2585343C (https=)
ES (1) ES2538305T3 (https=)
IL (1) IL182782A (https=)
NO (1) NO342460B1 (https=)
RU (1) RU2422513C2 (https=)
WO (1) WO2006047569A2 (https=)
ZA (1) ZA200704252B (https=)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105168250B (zh) 2004-10-25 2019-02-05 塞勒兰特治疗公司 增殖骨髓细胞群体的方法及其应用
US7811815B2 (en) * 2004-11-15 2010-10-12 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic uses of allogeneic myeloid progenitor cells
US20060182723A1 (en) * 2005-01-25 2006-08-17 Spellberg Brad J Methods for treating refractory infections in neutropenic individuals
US8383095B2 (en) * 2006-02-14 2013-02-26 Cellerant Therapeutics, Inc. Methods and compositions for enhancing engraftment of hematopoietic stem cells
US9394520B2 (en) 2006-12-08 2016-07-19 University Of Rochester Expansion of hematopoietic stem cells
US20120177610A1 (en) 2007-09-19 2012-07-12 Kieu Hoang Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin , and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin / Apo/Human Albumin/A1AT and all new found proteins
CA2711549C (en) * 2008-01-08 2016-08-23 The University Of Queensland Method of producing a population of cells
US20110293574A1 (en) * 2008-09-26 2011-12-01 Chute John P Hematopoietic stem cell growth factor
CN103540566A (zh) * 2008-11-14 2014-01-29 路易斯维尔大学研究基金会有限公司 用于长期造血种群恢复的方法和组合物
JP2010193879A (ja) * 2009-01-27 2010-09-09 Jms Co Ltd 臍帯血造血幹細胞の増殖制御方法およびその用途
CN102802686A (zh) * 2009-06-18 2012-11-28 Mc2细胞有限责任公司 骨髓胞外基质提取物及其治疗用途
CN102725400A (zh) * 2009-06-29 2012-10-10 麻省理工学院 制造人源化的非人类哺乳动物的方法
US20130095079A1 (en) * 2010-04-09 2013-04-18 Fred Hutchinson Cancer Research Center Compositions and methods for providing hematopoietic function without hla matching
US20130095080A1 (en) * 2010-04-09 2013-04-18 Fred Hutchinson Cancer Reserach Center Compositions and methods for providing hematopoietic function
AU2011323729B2 (en) * 2010-10-25 2016-08-04 The Children's Hospital Of Philadelphia Compositions and methods for the generation of platelets and methods of use thereof
CA3065694A1 (en) * 2010-11-10 2012-05-18 Inregen Methods of forming injectable formulations for providing regenerative effects to an organ such as a kidney
US9476029B2 (en) * 2010-11-13 2016-10-25 Lung-Ji Chang Ex vivo development, expansion and in vivo analysis of a novel lineage of dendritic cells
US20140205582A1 (en) * 2011-07-06 2014-07-24 Cellerant Therapeutics, Inc. Megakaryocyte progenitor cells for production of platelets
EP3785767A1 (en) * 2011-12-02 2021-03-03 Fate Therapeutics, Inc. Enhanced stem cell composition
CA2858069C (en) 2011-12-08 2020-02-11 Novartis Ag Compositions and methods for enhanced generation of hematopoietic stem/progenitor cells
TW201335181A (zh) * 2012-01-31 2013-09-01 Kieu Hoang ５５種新發現的蛋白質之序列及其應用
JP6429191B2 (ja) * 2012-03-06 2018-11-28 セレクト バイオセラピューティクス リミテッド アポトーシスシグナル伝達抵抗性細胞を選択する装置および方法ならびにその使用
ES2681050T3 (es) 2012-04-11 2018-09-11 Acerta Pharma B.V. Inhibidores de la tirosina quinasa de Bruton para la movilización hematopoyética
GB201210857D0 (en) 2012-06-19 2012-08-01 Cambridge Entpr Ltd Transcription factor mediated programming towards megakaryocytes
US9074186B2 (en) 2012-08-15 2015-07-07 Boston Medical Center Corporation Production of red blood cells and platelets from stem cells
JP6372782B2 (ja) * 2012-09-28 2018-08-15 公益財団法人神戸医療産業都市推進機構 虚血性疾患治療に適した細胞を含む細胞群の生体外増幅方法
CA3177929A1 (en) 2012-12-21 2014-06-26 Astellas Institute For Regenerative Medicine Methods for production of platelets from pluripotent stem cells and compositions thereof
EP2943566A1 (en) 2013-01-08 2015-11-18 Fred Hutchinson Cancer Research Center Compositions and methods for expansion of embryonic hematopoietic stem cells
WO2014159685A2 (en) 2013-03-14 2014-10-02 Mylan Inc. Glatiramer acetate response biomarker mrna potency assay
ES2686851T3 (es) * 2013-04-09 2018-10-22 Inserm - Institut National De La Santé Et De La Recherche Médicale Uso de M-CSF para prevenir o tratar la citopenia mieloide y las complicaciones relacionadas
JP2016538253A (ja) * 2013-10-09 2016-12-08 セレクト バイオセラピューティクス リミテッド デスリガンドへの移植前曝露による造血前駆細胞の活性化
WO2015057992A1 (en) 2013-10-16 2015-04-23 Izumi Raquel Btk inhibitors for hematopoietic mobilization
US9995734B2 (en) 2013-10-24 2018-06-12 Mylan Inc. Human T cell line assay for evaluating the immunologic identity of glatiramer acetate preparations
MX389160B (es) 2013-10-31 2025-03-20 Hutchinson Fred Cancer Res Células no t efectoras y madre/progenitoras hematopoyéticas modificadas y usos de estas.
JP2016104711A (ja) * 2014-11-21 2016-06-09 国立大学法人 東京大学 造血幹細胞移植を補助することに用いるための医薬組成物およびその製造方法
US10350245B2 (en) 2015-01-21 2019-07-16 Fred Hutchinson Cancer Research Center Point-of-care and/or portable platform for gene therapy
US20170151281A1 (en) 2015-02-19 2017-06-01 Batu Biologics, Inc. Chimeric antigen receptor dendritic cell (car-dc) for treatment of cancer
WO2016176651A2 (en) 2015-04-29 2016-11-03 Fred Hutchinson Cancer Research Center Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof
EP3288570A4 (en) 2015-04-29 2018-11-21 Fred Hutchinson Cancer Research Center Modified stem cells and uses thereof
US11312940B2 (en) 2015-08-31 2022-04-26 University Of Louisville Research Foundation, Inc. Progenitor cells and methods for preparing and using the same
MX2018006828A (es) * 2015-12-04 2018-08-09 Hutchinson Fred Cancer Res Usos de poblaciones expandidas de celulas madre/progenitoras hematopoyeticas.
US11072777B2 (en) 2016-03-04 2021-07-27 University Of Louisville Research Foundation, Inc. Methods and compositions for ex vivo expansion of very small embryonic-like stem cells (VSELs)
CN105713880A (zh) * 2016-04-20 2016-06-29 广东艾时代生物科技有限责任公司 一种造血干细胞体外扩增培养的无血清培养基及其应用
CA3027668A1 (en) * 2016-07-12 2018-01-18 Matinas Biopharma Nanotechnologies, Inc. Encochleated antifungal compounds for central nervous system delivery and treatment of cryptococcus infections
JP7038369B2 (ja) 2016-08-22 2022-03-18 国立大学法人 鹿児島大学 ウシ生殖細胞の凍結保存用組成物及び凍結保存方法
GB201618106D0 (en) * 2016-10-26 2016-12-07 Lift Biosciences Ltd Cancer-killing cells
CN107858330B (zh) * 2017-11-20 2021-08-27 上海中医药大学 一种小鼠骨髓造血干/祖细胞体外衰老细胞模型的建立方法
JP7273421B2 (ja) 2018-02-21 2023-05-15 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム ナチュラルキラー細胞の活性化および拡大のための方法ならびにその使用
FR3084463B1 (fr) * 2018-07-30 2023-04-21 Francais Du Sang Ets Procede d'analyse des plaquettes d'un echantillon sanguin
EP3849565A4 (en) 2018-09-12 2022-12-28 Fred Hutchinson Cancer Research Center REDUCTION OF CD33 EXPRESSION TO SELECTIVELY PROTECT THERAPEUTIC CELLS
CN111004781A (zh) 2018-10-08 2020-04-14 南加利福尼亚大学 长期扩增粒细胞-巨噬细胞祖细胞的方法及其应用
EP3876977A1 (en) 2018-11-06 2021-09-15 The Regents Of The University Of California Chimeric antigen receptors for phagocytosis
WO2020206267A1 (en) * 2019-04-03 2020-10-08 Akron Biotechnology, Llc Cryopreservation and cell culture media
US11013764B2 (en) 2019-04-30 2021-05-25 Myeloid Therapeutics, Inc. Engineered phagocytic receptor compositions and methods of use thereof
AU2020265737A1 (en) * 2019-05-01 2021-12-02 Immunebridge Inc. Methods of making oligopotent and unipotent precursors
WO2020247341A1 (en) * 2019-06-06 2020-12-10 Medeor Therapeutics, Inc. Methods of making cellular products by post-mortem mobilization and harvesting of hematopoietic cells
JP7831937B2 (ja) 2019-09-03 2026-03-17 クリエイト・メディシンズ，インコーポレーテッド ゲノム組込みのための方法および組成物
US10980836B1 (en) 2019-12-11 2021-04-20 Myeloid Therapeutics, Inc. Therapeutic cell compositions and methods of manufacturing and use thereof
CA3197423A1 (en) 2020-11-04 2022-05-12 Daniel Getts Engineered chimeric fusion protein compositions and methods of use thereof
EP4308133A4 (en) 2021-03-17 2025-01-22 Myeloid Therapeutics, Inc. MANIPULATED CHIMERIC FUSION PROTEIN COMPOSITIONS AND METHODS OF USE THEREOF
AU2022272235A1 (en) 2021-05-11 2023-12-21 Create Medicines, Inc. Methods and compositions for genomic integration
AU2023216659A1 (en) * 2022-02-01 2024-08-15 Bluerock Therapeutics Lp Methods for treating inherited metabolic disorders
EP4476331A2 (en) 2022-02-07 2024-12-18 Ensoma, Inc. Inhibitor-resistant mgmt modifications and modification of mgmt-encoding nucleic acids
WO2025116531A1 (ko) * 2023-11-27 2025-06-05 한양대학교 산학협력단 체외 배양을 통해 개의 조혈모세포나 적혈구전구세포로부터 적혈구를 생산하는 방법

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE81724T1 (de) * 1987-11-09 1992-11-15 Becton Dickinson Co Verfahren zur analyse haematopoietischer zellen in einer probe.
US5004681B1 (en) 1987-11-12 2000-04-11 Biocyte Corp Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood
US6433142B1 (en) * 1989-08-08 2002-08-13 Genetics Institute, Llc Megakaryocyte stimulating factors
US6852313B1 (en) * 1989-10-16 2005-02-08 Amgen Inc. Method of stimulating growth of melanocyte cells by administering stem cell factor
US5061620A (en) * 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5840580A (en) 1990-05-01 1998-11-24 Becton Dickinson And Company Phenotypic characterization of the hematopoietic stem cell
US6326198B1 (en) * 1990-06-14 2001-12-04 Regents Of The University Of Michigan Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
NZ255039A (en) 1992-07-10 1997-03-24 Univ Pittsburgh Mammalian hematopoietic facilitatory cells and their use in preventing graft-versus-host disease in bone marrow transplants
US5772992A (en) * 1992-11-24 1998-06-30 G.D. Searle & Co. Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors
SK100896A3 (en) * 1994-02-14 1997-10-08 Zymogenetics Inc Hematopoietic protein and materials and methods for making it
DE4422667A1 (de) * 1994-06-30 1996-01-04 Boehringer Ingelheim Int Verfahren zur Herstellung und Züchtung hämatopoetischer Vorläuferzellen
US6103522A (en) * 1994-07-20 2000-08-15 Fred Hutchinson Cancer Research Center Human marrow stromal cell lines which sustain hematopoiesis
US5986049A (en) * 1994-12-30 1999-11-16 Zymogenetics, Inc. Purified thrombopoietin and method of making it
US5821108A (en) * 1995-04-07 1998-10-13 The Board Of Trustees Of The Leland Stanford Junior University Enrichment for a thymocyte subset having progenitor cell activity using c-kit as a selection marker
US5925567A (en) * 1995-05-19 1999-07-20 T. Breeders, Inc. Selective expansion of target cell populations
US6013067A (en) * 1995-06-07 2000-01-11 Zymogenetics, Inc. Methods for increasing hematopoietic cells
US5877299A (en) 1995-06-16 1999-03-02 Stemcell Technologies Inc. Methods for preparing enriched human hematopoietic cell preparations
DE19600589C1 (de) * 1996-01-10 1997-01-16 Univ Eberhard Karls Antikörper A3C6E2
EP0891419A4 (en) * 1996-03-12 2000-03-01 Life Technologies Inc NUTRIENT ADDITIVE FOR HEMATOPOETIC CELL CULTURES
US5843633A (en) * 1996-04-26 1998-12-01 Amcell Corporation Characterization of a human hematopoietic progenitor cell antigen
US6335195B1 (en) * 1997-01-28 2002-01-01 Maret Corporation Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
US6908763B1 (en) 1997-08-22 2005-06-21 The Board Of Trustees Of The Leland Stanford Junior University Mammalian common lymphoid progenitor cell
US6982082B1 (en) * 1997-08-27 2006-01-03 President And Fellows Of Harvard College Gene therapy by cell specific targeting
US6558662B2 (en) * 1997-11-14 2003-05-06 The General Hospital Corporation Treatment of hematologic disorders
ES2252932T3 (es) * 1998-02-05 2006-05-16 Novartis Ag Poblaciones expandidas y geneticamente modificadas de celulas madre hematopoyeticas humanas.
AU4336599A (en) * 1998-06-08 1999-12-30 Osiris Therapeutics, Inc. (in vitro) maintenance of hematopoietic stem cells
US20030060425A1 (en) * 1998-11-24 2003-03-27 Ahlem Clarence N. Immune modulation method using steroid compounds
WO2000057891A1 (en) * 1999-03-30 2000-10-05 Trustees Of Boston University Compositions and methods for producing platelets and/or proplatelets from megakaryocytes
CA2369085A1 (en) * 1999-05-14 2000-11-23 City Of Hope Ex vivo expansion of mammalian hematopoietic stem cells
US6761883B2 (en) * 1999-06-29 2004-07-13 The Board Of Trustees Of The Leland Stanford Junior University Mammalian myeloid progenitor cell subsets
CA2375974C (en) 1999-06-29 2010-11-02 The Board Of Trustees Of The Leland Stanford Junior University Mammalian myeloid progenitor cell subsets
AU784513B2 (en) 2000-01-18 2006-04-27 Board Of Trustees Of The Leland Stanford Junior University Expansion of stem and progenitor cells by beta-catenin
US7311905B2 (en) * 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
ES2378524T3 (es) 2002-09-13 2012-04-13 The Board Of Trustees Of The Leland Stanford Junior University Célula progenitora de megacariocitos de mamífero
US6751883B2 (en) 2002-11-21 2004-06-22 Huei-Yen Liao Reel rotation mount arrangement equipped with friction reduction means for tape measure
AU2003295444A1 (en) * 2002-11-15 2004-06-15 The Board Of Trustees Of The University Of Illinois Methods for in vitro expansion of hematopoietic stem cells
US20040241856A1 (en) * 2003-02-12 2004-12-02 Irm Llc, A Delaware Limited Liability Company Methods and compositions for modulating stem cells
US20050215473A1 (en) * 2003-05-09 2005-09-29 Enrique Alvarez Prophylactic and therapeutic uses of FGF-20 in radiation protection
US20050118147A1 (en) * 2003-11-17 2005-06-02 Il-Hoan Oh Method of using mesenchymal stromal cells to increase engraftment
CN105168250B (zh) 2004-10-25 2019-02-05 塞勒兰特治疗公司 增殖骨髓细胞群体的方法及其应用
US7811815B2 (en) * 2004-11-15 2010-10-12 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic uses of allogeneic myeloid progenitor cells
US8383095B2 (en) * 2006-02-14 2013-02-26 Cellerant Therapeutics, Inc. Methods and compositions for enhancing engraftment of hematopoietic stem cells

Similar Documents

Publication Publication Date Title
JP2008517948A5 (https=)
RU2422513C2 (ru) Способы экспансии популяций миелоидных клеток и их использование
Luevano et al. Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapy
Sitnicka et al. Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool
US11439667B2 (en) Compositions and methods for expansion of embryonic hematopoietic stem cells
EP3097917B1 (en) Compositions and methods for providing hematopoietic function without hla matching
Meaker et al. Ex vivo hematopoietic stem cell expansion technologies: recent progress, applications, and open questions
CN102144028B (zh) 造血前体的扩增
CA3090548C (en) COMPOSITIONS AND METHODS FOR PROVIDING HEMATOPOIETIC FUNCTION
Baron et al. Methods of ex vivo expansion of human cord blood cells: challenges, successes and clinical implications
CN104066837A (zh) 增强的干细胞组合物
JP7467358B2 (ja) 免疫応答を媒介するｉｎ ｖｉｖｏでのＮＫ細胞およびＤＣ細胞の拡大
JP3058353B2 (ja) 造血細胞の増加方法
CN113454207A (zh) 用新型芳香族化合物扩增自然杀伤细胞和ilc3细胞
WO2017023918A1 (en) Methods for the mobilization and use of t-cells with enhanced reconstitution potential and life-span
CN109843304A (zh) 使用自然杀伤细胞治疗急性髓性白血病和多发性骨髓瘤的方法
ES2369487T3 (es) Combinación farmacéutica de g-csf y plgf útil para células madre de sangre.
WO2021016621A1 (en) Populations of natural killer cells comprising a cd38 chimeric antigen receptor
Rejeski et al. Concentration-dependent effects of immunomodulatory cocktails on the generation of leukemia-derived dendritic cells, DCleu mediated T-cell activation and on-target/off-tumor toxicity
Mayani Notch signaling: from stem cell expansion to improving cord blood transplantation
Ageyama et al. Safe and efficient methods of autologous hematopoietic stem cell transplantation for biomedical research in cynomolgus monkeys
JPWO2019161494A5 (https=)
Zhao et al. Rapid immune reconstitution and dendritic cell engraftment post–bone marrow transplantation with heterogeneous progenitors and GM-CSF treatment
Kanz et al. Ex vivo manipulation of hematopoietic stem and progenitor cells
LILL et al. Defined Cell Populations